These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 24252307)

  • 1. Increasing the use of statins in people at low cardiovascular risk is difficult.
    Majeed A
    BMJ; 2013 Nov; 347():f6901. PubMed ID: 24252307
    [No Abstract]   [Full Text] [Related]  

  • 2. All people over 75 years with a five-year CVD risk of ≥15% should be treated with statins unless specifically contraindicated: yes.
    Wells S
    J Prim Health Care; 2010 Dec; 2(4):330-2. PubMed ID: 21125075
    [No Abstract]   [Full Text] [Related]  

  • 3. Utilization of statins: guiding principles and the new United States guidelines.
    Hennekens CH; Gelb IJ
    Cardiology; 2014; 128(1):41-2. PubMed ID: 24514943
    [No Abstract]   [Full Text] [Related]  

  • 4. Battle of the statins, or how the news media can change patient care.
    Hegmann T
    JAAPA; 2004 Jan; 17(1):9-11. PubMed ID: 15307332
    [No Abstract]   [Full Text] [Related]  

  • 5. Physician support for a population-based pharmaceutical approach to cardiovascular prevention: not there yet.
    Huy C; Litaker D
    Prev Med; 2011 Jan; 52(1):18-9. PubMed ID: 21130110
    [No Abstract]   [Full Text] [Related]  

  • 6. Patient and other factors influencing the prescribing of cardiovascular prevention therapy in the general practice setting with and without nurse assessment.
    Mohammed MA; El Sayed C; Marshall T
    Med Decis Making; 2012; 32(3):498-506. PubMed ID: 22357626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice.
    Keller H; Krones T; Becker A; Hirsch O; Sönnichsen AC; Popert U; Kaufmann-Kolle P; Rochon J; Wegscheider K; Baum E; Donner-Banzhoff N
    Eur J Prev Cardiol; 2012 Jun; 19(3):322-9. PubMed ID: 21450565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O; Welten GM; Bax JJ; Poldermans D
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract]   [Full Text] [Related]  

  • 9. Intermittent claudication: a plea for guidelines for medical management.
    Powell JT
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):451-2. PubMed ID: 17196850
    [No Abstract]   [Full Text] [Related]  

  • 10. New analysis fuels debate on merits of prescribing statins to low risk people.
    Kmietowicz Z
    BMJ; 2014 Mar; 348():g2370. PubMed ID: 24671956
    [No Abstract]   [Full Text] [Related]  

  • 11. President's page: the promise of prevention: so, why aren't all cardiologists "preventive"?
    Wolk MJ; Bairey Merz CN; Thompson PD
    J Am Coll Cardiol; 2004 Nov; 44(10):2082-4. PubMed ID: 15542296
    [No Abstract]   [Full Text] [Related]  

  • 12. Physician-specific variation in medication adherence among diabetes patients.
    Sherman BW; Sekili A; Prakash ST; Rausch CA
    Am J Manag Care; 2011 Nov; 17(11):729-36. PubMed ID: 22084892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The healthy adherer effect.
    Andersohn F; Willich SN
    Arch Intern Med; 2009 Sep; 169(17):1635-6; author reply 1636. PubMed ID: 19786686
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of aspirin and statins for cardiovascular risk reduction in New Zealand: the residential care story.
    Hong JB; Kerse N; Scahill S; Moyes S; Chen C; Peri K; Hughes C
    J Prim Health Care; 2009 Sep; 1(3):184-9. PubMed ID: 20690381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Lipid therapy in daily routine].
    Sonntag F; Schaefer JR; Gitt AK; Weizel A; Jannowitz C; Karmann B; Pittrow D; Bestehorn K
    Dtsch Med Wochenschr; 2012 Oct; 137(40):2047-52. PubMed ID: 23023622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins: putting the benefit/risk into perspective.
    Shepherd J
    Int J Clin Pract Suppl; 2003 Oct; (137):27-33. PubMed ID: 14649699
    [No Abstract]   [Full Text] [Related]  

  • 17. Summaries for patients. Comparative effectiveness of generic and brand-name statins on patient outcomes.
    Ann Intern Med; 2014 Sep; 161(6):I-30. PubMed ID: 25222407
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of hyperlipidemia in older adults.
    Alexander KP; Blazing MA; Rosenson RS; Hazard E; Aronow WS; Smith SC; Ohman EM
    J Cardiovasc Pharmacol Ther; 2009 Mar; 14(1):49-58. PubMed ID: 19124599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events Including Physicians' Experience and Evaluation).
    Assmann G; Benecke H; Neiss A; Cullen P; Schulte H; Bestehorn K
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):776-83. PubMed ID: 17001218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Questioning the benefits of statins.
    Mazowita G
    CMAJ; 2005 Nov; 173(10):1210; author reply 1210. PubMed ID: 16275979
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.